Page last updated: 2024-12-10
disperse blue 79
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 2825062 |
| SCHEMBL ID | 20472277 |
| SCHEMBL ID | 20472276 |
| MeSH ID | M0415249 |
Synonyms (29)
| Synonym |
|---|
| 2-[5-acetamido-n-(2-acetyloxyethyl)-4-[(2-bromo-4,6-dinitrophenyl)diazenyl]-2-ethoxyanilino]ethyl acetate |
| disperse blue 79 |
| 2,2'-((5-acetamide-4-((2-bromo-4,6-dinitrophenyl)azo)-2-ethoxyphenyl)imino)diethyl diacetate |
| c.i. disperse blue 79 |
| acetamide, n-(5-(bis(2-(acetyloxy)ethyl)amino)-2-(2-(2-bromo-4,6-dinitrophenyl)diazenyl)-4-ethoxyphenyl)- |
| einecs 235-475-5 |
| 4-(2-bromo-4,6-dinitrophenylazo)-5-acetylamino-2-ethoxy-n,n-bis(beta-acetoxyethyl)aniline |
| 5h8o3yer4s , |
| unii-5h8o3yer4s |
| 12239-34-8 |
| acetamide, n-(5-(bis(2-(acetyloxy)ethyl)amino)-2-((2-bromo-4,6-dinitrophenyl)azo)-4-ethoxyphenyl)- |
| AKOS022179624 |
| DTXSID5044524 |
| AKOS024434558 |
| W-110301 |
| p-acetophenetidide, 5'-(bis(2-hydroxyethyl)amino)-2'-((2-bromo-4,6-dinitrophenyl)azo)-, diacetate |
| ci disperse blue 79 |
| 2'-acetylamino-4'-(bis(acetoxyethyl)amino)-6-bromo-2,4-dinitro-5'-ethoxyazobenzene |
| c.i. 11345 |
| 2-bromo-4,6-dinitrophenylazo-2-acetamido-4-di-(2-acetoxyethyl)amino-5-ethoxybenzene |
| ci 11345 |
| 2-acetamido-4-(n,n-bis(.beta.-acetoxyethyl)amino)-5-ethoxy-2'-bromo-4',6'-dinitroazobenzene |
| 2-{5-(acetylamino)[2-(acetyloxy)ethyl]-4-[(e)-(2-bromo-4,6-dinitrophenyl)diazenyl]-2-ethoxyanilino}ethyl acetate |
| n-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-ethoxyphenyl]-acetamide |
| disperse blue 79 (c.i. 11345) |
| SCHEMBL20472277 |
| SCHEMBL20472276 |
| Q27262175 |
| 2-{5-(acetylamino)[2-(acetyloxy)ethyl]-4-[2-(2-bromo-4,6-dinitrophenyl)diaz-1-enyl]-2-ethoxyanilino}ethyl acetate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 25.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.84) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||